Author

Andrei Popescu

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Observed institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

OpenAlex ID: A5121365474

Preclinical development of MK‐2214 a novel antibody targeting pS413 tau for the treatment of Alzheimer’s Disease

2025 · Jonathan A Sugam, Seth Robey, et al. · Alzheimer s & Dementia · 1

Population-scale immune multiome atlas reveals regulatory disease mechanisms

2026 · Masahiro Kanai, Toni M. Delorey, et al. · Nature

Association and risk prediction of 19 complex diseases with polygenic scores and socioeconomic status

2026 · Fiona A. Hagenbeek, Anne Richmond, et al. · Communications Medicine

Works count: 3

Citation count: 1

H-index: 1

I10-index: